ANGELA HAGERTY: Open Payments
NPI 1750972030 · GRANTS PASS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 17 payments from 8 companies in 2025. Trend: 2023 $358 · 2024 $220 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $166 |
| Novo Nordisk Inc | 2 | $48 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| PFIZER INC. | 1 | $21 |
Products named: REXULTI, TRELEGY ELLIPTA, AIRSUPRA, Wegovy, ZENPEP, The Cologuard Plus Collection Kit, VRAYLAR, NURTEC ODT.
Industry payments across OR — which companies pay providers there.
